The median CSF κ‐FLC levels were comparable between patients in the GFAP‐astrocytopathy and MS groups (3.7 [1.6; 8.4] mg/L vs. 3.6 [2.4; 8.5] mg/L, p = 0.805). Here, GFAP is linked to myeloid sarcoma.